Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 1 of 1 entries
Sorted by: Best Match Show Resources per page
New Developments in Peptide Receptor Radionuclide Therapy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Nicolas GP, Morgenstern A, Schottelius M, Fani M.
PMID: 30573642
J Nucl Med. 2018 Dec 20; doi: 10.2967/jnumed.118.213496. Epub 2018 Dec 20.

Peptide Receptor Radionuclide Therapy (PRRT) is an established treatment for non-operable or metastatic neuroendocrine neoplasms that express highly and frequently somatostatin receptors. More generally, PRRT is an attractive therapy option for delivering cytotoxic radiation to tumor cells through specific...

Cite
Nicolas GP, Morgenstern A, Schottelius M, et al. New Developments in Peptide Receptor Radionuclide Therapy. J Nucl Med. 2018;doi: 10.2967/jnumed.118.213496.
Nicolas, G. P., Morgenstern, A., Schottelius, M., & Fani, M. (2018). New Developments in Peptide Receptor Radionuclide Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, . https://doi.org/10.2967/jnumed.118.213496
Nicolas, Guillaume P, et al. "New Developments in Peptide Receptor Radionuclide Therapy." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. (2018). doi: https://doi.org/10.2967/jnumed.118.213496
Nicolas GP, Morgenstern A, Schottelius M, Fani M. New Developments in Peptide Receptor Radionuclide Therapy. J Nucl Med. 2018 Dec 20; doi: 10.2967/jnumed.118.213496. Epub 2018 Dec 20. PMID: 30573642.
Copy Download .nbib Format: NLM
Showing 1 to 1 of 1 entries